AGL-2263
Code | Size | Price |
---|
TAR-T14142-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14142-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
AGL-2263 is a blocker of insulin receptor (IR)
CAS:
638213-98-6
Formula:
C17H10N2O5
Molecular Weight:
322.276
Pathway:
Tyrosine Kinase/Adaptors
Purity:
0.98
SMILES:
Oc1ccc(cc1O)C(=O)C(=Cc1ccc2oc(=O)[nH]c2c1)C#N
Target:
IGF-1R
References
1. Li Y, et al. GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake. Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5697-705.